TGFB1 and ovarian carcinoma: Exposure of ovarian cancer cell lines to TGFβ, which is one of the ascites cytokines involved in resistance17–20, did not increase JAK-STAT expression or alter cisplatin sensitivity (Supplementary Fig. 6c–e).